Pfizer Inc and BioNTech have asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged five to 11, Pfizer said in a tweet on Thursday.
Pfizer, BioNTech seek COVID-19 vaccine approval for children 5 to 11 (Reuters)
by Family Voices, Inc. | Oct 7, 2021 | Vaccine Outreach